NASDAQ:BCAC Brookline Capital Acquisition (BCAC) Stock Forecast, Price & News $0.52 -0.02 (-3.72%) (As of 06/7/2023 ET) Add Compare Share Share Today's Range$0.50▼$0.5450-Day Range$0.34▼$0.6252-Week Range$9.50▼$27.74Volume72,333 shsAverage Volume39,682 shsMarket Capitalization$3.49 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Brookline Capital Acquisition (NASDAQ:BCAC) StockBrookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire companies in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.Read More Receive BCAC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Brookline Capital Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address BCAC Stock News HeadlinesJune 5, 2023 | americanbankingnews.comBrookline Capital Acquisition (NASDAQ:BCAC) versus Compugen (NASDAQ:CGEN) Critical ReviewMay 25, 2023 | seekingalpha.comLFAC LF Capital Acquisition Corp. IIJune 8, 2023 | Behind the Markets (Ad)[BREAKING] New "Living Software" to Revolutionize WarfareThis breakthrough will change "the way wars will be fought, and won, for years to come." - Chairman of the Joint Chief of Staff, General Mark Milley Get the name of the company supplying it to the U.S. Army here >>>May 8, 2023 | americanbankingnews.comHead-To-Head Contrast: Sutro Biopharma (NASDAQ:STRO) vs. Brookline Capital Acquisition (NASDAQ:BCAC)April 30, 2023 | americanbankingnews.comBrookline Capital Acquisition (NASDAQ:BCAC) Trading Up 5.9%April 6, 2023 | benzinga.comBrookline Capital Downgrades Oncternal Therapeutics to HoldDecember 30, 2022 | yahoo.comBrookline Bancorp, Inc. Announces Preliminary Results of Merger Consideration Elections Regarding Pending PCSB Financial Corporation MergerAugust 1, 2022 | finance.yahoo.comApexigen Completes Business Combination to Become a Publicly Listed Immuno-oncology CompanyJune 8, 2023 | Behind the Markets (Ad)[BREAKING] New "Living Software" to Revolutionize WarfareThis breakthrough will change "the way wars will be fought, and won, for years to come." - Chairman of the Joint Chief of Staff, General Mark Milley Get the name of the company supplying it to the U.S. Army here >>>June 29, 2022 | nz.finance.yahoo.comApexigen Announces Board Appointment and New ChairJune 8, 2022 | finance.yahoo.comApexigen Appoints William Duke as Chief Financial OfficerMay 9, 2022 | tmcnet.comApexigen to Host Investor Day on Antibody Therapeutic Pipeline and Unique APXiMAB™ PlatformMarch 23, 2022 | benzinga.comBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Mount Rainier Acquisition Corp. (Nasdaq - RNER), Brookline Capital Acquisition Corp. (Nasdaq - BCAC), Vickers Vantage Corp. I (Nasdaq - VCKA), Pono Capital Corp (Nasdaq - PONO)March 18, 2022 | seekingalpha.comCancer focused Apexigen to go public via deal with SPAC Brookline CapitalJanuary 24, 2022 | nasdaq.comBrookline Capital Acquisition Corp. Common Stock (BCAC)August 27, 2021 | barrons.comBrookline Capital Acquisition Corp.July 26, 2021 | finance.yahoo.comBrookline Capital Markets Hosts Biotech Symposium TodayJune 25, 2021 | msn.comBRIEF-Blank Check Co Inception Growth Acquisition Files For IPO Of Up To $90 MlnJune 22, 2021 | prnewswire.comGolden Path Acquisition Corporation Announces Pricing of Initial Public OfferingJune 15, 2021 | msn.comBRIEF-Nova Vision Acquisition Corp - Proposed IPO Price Is An Estimate Solely For Purpose Of Calculating SEC Registration FeeJune 11, 2021 | prnewswire.comOcean Biomedical, Inc. Files Registration Statement For Proposed Initial Public OfferingMay 14, 2021 | investing.comBrookline Capital Acquisition Corp (BCACU)May 14, 2021 | markets.businessinsider.comBespoke Capital Acquisition Corp. Reports First Quarter 2021 Financial ResultsApril 26, 2021 | markets.businessinsider.comBespoke Capital Provides Update on Proposed Combination With Vintage Wine EstatesApril 21, 2021 | ca.finance.yahoo.comIQHQ Announces Start of Construction on $1 Billion Fenway Center Life Science CampusApril 16, 2021 | in.finance.yahoo.comReplay: IPO Edge Hosts Virtual Forum and Tasting with Bespoke, Vintage Wine EstatesMarch 31, 2021 | markets.businessinsider.comCELSION CORPORATION ANNOUNCES $15 MILLION REGISTERED DIRECT OFFERINGSee More Headlines BCAC Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BCAC Company Calendar Today6/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Biological Products, Except Diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:BCAC CUSIPN/A CIK1814140 Webwww.brooklinecapitalacquisitioncorp.com Phone646-643-6716FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-480,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-416.32% Return on Assets-4.75% Debt Debt-to-Equity RatioN/A Current Ratio0.07 Quick Ratio0.07 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares6,746,000Free Float5,451,000Market Cap$3.49 million OptionableNot Optionable Beta-0.03 Key ExecutivesDr. Samuel P. Wertheimer Ph.D.Chairman & CEOMr. Scott A. Katzmann (Age 66)Pres & Director Mr. Patrick SturgeonChief Financial OfficerKey CompetitorsFresh Tracks TherapeuticsNASDAQ:FRTXPolarityTENASDAQ:PTEBiondVax PharmaceuticalsNASDAQ:BVXVKiromic BioPharmaNASDAQ:KRBPRubius TherapeuticsNASDAQ:RUBYView All Competitors BCAC Stock - Frequently Asked Questions How have BCAC shares performed in 2023? Brookline Capital Acquisition's stock was trading at $0.6820 at the start of the year. Since then, BCAC shares have decreased by 24.1% and is now trading at $0.5175. View the best growth stocks for 2023 here. What is Brookline Capital Acquisition's stock symbol? Brookline Capital Acquisition trades on the NASDAQ under the ticker symbol "BCAC." How do I buy shares of Brookline Capital Acquisition? Shares of BCAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Brookline Capital Acquisition's stock price today? One share of BCAC stock can currently be purchased for approximately $0.52. How much money does Brookline Capital Acquisition make? Brookline Capital Acquisition (NASDAQ:BCAC) has a market capitalization of $3.49 million. How can I contact Brookline Capital Acquisition? Brookline Capital Acquisition's mailing address is 600 LEXINGTON AVENUE 33RD FLOOR, NEW YORK NY, 10022. The official website for the company is www.brooklinecapitalacquisitioncorp.com. The company can be reached via phone at 646-643-6716. This page (NASDAQ:BCAC) was last updated on 6/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brookline Capital Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.